Below are the financial statements of Crinetics Pharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenues | 1.04a | 4.01a | 4.74a |
| Operating expenses | — | — | — |
| Research and development | -240.16a | -168.53a | -130.23a |
| General and administrative | -99.74a | -58.09a | -42.39a |
| Total operating expenses | -339.89a | -226.62a | -172.62a |
| Loss from operations | -338.85a | -222.61a | -167.88a |
| Other income (expense) | — | — | — |
| Interest income | 41.44a | 13.44a | 4.32a |
| Change in fair value of derivative asset | 0a | 0a | 0.6a |
| Other income (expense), net | -0.52a | -0.16a | 0.06a |
| Total other income, net | 40.92a | 13.28a | 4.97a |
| Loss before equity method investment | -297.94a | -209.33a | -162.91a |
| Loss on equity method investment | -0.47a | -5.2a | -1.01a |
| Net loss | -298.41a | -214.53a | -163.92a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Crinetics Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.